936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of the MDM2 inhibitor DS-3032b in patients (pts) with advanced solid tumors and lymphomas
    Meeting Abstract

    Gounder, M. M.; Bauer, T. M.; Schwartz, G. K.; Masters, T.; Carvajal, R. D.; Song, S.; Kumar, P.; Gajee, R.; Zernovak, O.; Rosen, M. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The Selinexor in Advanced Liposarcoma (SEAL) study: A phase 2/3, multicenter, randomized, double blind study of selinexor versus placebo in patients with advanced, unresectable, dedifferentiated liposarcoma (DDLS)
    Meeting Abstract

    Gounder, M. M.; Wagner, A. J.; Somaiah, N.; Riedel, R. F.; Schwartz, G. K.; Atti, S.; Razak, A. R. A.; Cranmer, L. D.; Okuno, S. H.; Milhem, M. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma
    Meeting Abstract

    Agulnik, M.; Tannir, N. M.; Pressey, J. G.; Gounder, M. M.; Cote, G. M.; Roche, M.; Doleman, S.; Blakemore, S. J.; Clawson, A.; Daigle, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Platelet-derived growth factor receptor alpha promotes cancer stem-like cell phenotypes in sarcomas including metastasis and chemotherapy resistance
    Meeting Abstract

    Chang, K. K.; Yoon, C.; Tap, W. D.; Yoon, S. S.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • Chronic imatinib (> 3 years) therapy after complete resection of primary, high-risk gastrointestinal stromal tumor (GIST) is associated with low recurrence
    Meeting Abstract

    Cavnar, M. J.; Balachandran, V. P.; Chi, P.; Keohan, M. L.; Tap, W. D.; DeMatteo, R. P.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • A randomized phase 1b/2 study evaluating the safety and efficacy of doxorubicin (dox) with or without olaratumab (IMC-3G3), a human anti-platelet-derived growth factor α (pdgfrα) monoclonal antibody, in advanced soft tissue sarcoma (sts)
    Meeting Abstract

    Tap, W.; Jones, R. L.; Chmielowski, B.; Elias, A. D.; Adkins, D.; Van Tine, B. A.; Agulnik, M.; Cooney, M.; Livingston, M. B.; Pennock, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021
    Meeting Abstract

    Tap, W.; Papai, Z.; van Tine, B.; Attia, S.; Ganjoo, K.; Jones, R. L.; Schuetze, S.; Reed, D.; Chawla, S. P.; Riedel, R.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Open label non-randomized multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1c259 SPEAR T-cellsTM in HLA-A*02+ patients with synovial sarcoma (NCT01343043)
    Meeting Abstract

    Mackall, C.; D'Angelo, S.; Grupp, S.; Glod, J.; Druta, M.; Chow, W.; Chagin, K.; Mehler, M.; Kari, G.; Trivedi, T.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Exposure-response of olaratumab for survival outcomes and safety when combined with doxorubicin in soft tissue sarcoma (STS) patients
    Meeting Abstract

    Jones, R.; Mo, G.; Baldwin, J. R.; Nichols, R. D.; Ilaria, R. L.; Conti, I.; Cronier, D. M.; Tap, W. D.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond
    Journal Article

    Kelly, C. M.; Janjigian, Y. Y.
    Journal of Gastrointestinal Oncology (2016)

    Fulltext@MSK | Save